Unusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C.
Identifieur interne : 001065 ( Main/Corpus ); précédent : 001064; suivant : 001066Unusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C.
Auteurs : Hafiz Muhammad Waqas Khan ; Niraj Parikh ; Shady Maher Megala ; George Silviu PredeteanuSource :
- The American journal of case reports [ 1941-5923 ] ; 2020.
English descriptors
- KwdEn :
- Aged (MeSH), Ascorbic Acid (administration & dosage), Betacoronavirus (MeSH), COVID-19 (MeSH), Coronavirus Infections (therapy), Female (MeSH), Humans (MeSH), Infusions, Intravenous (MeSH), Pandemics (MeSH), Pneumonia, Viral (therapy), Recovery of Function (MeSH), Respiration, Artificial (methods), SARS-CoV-2 (MeSH), Vitamins (administration & dosage).
- MESH :
- chemical , administration & dosage : Ascorbic Acid, Vitamins.
- methods : Respiration, Artificial.
- therapy : Coronavirus Infections, Pneumonia, Viral.
- Aged, Betacoronavirus, COVID-19, Female, Humans, Infusions, Intravenous, Pandemics, Recovery of Function, SARS-CoV-2.
Abstract
BACKGROUND Coronavirus disease 2019 (COVID-19) continues to spread, with confirmed cases now in more than 200 countries. Thus far there are no proven therapeutic options to treat COVID-19. We report a case of COVID-19 with acute respiratory distress syndrome who was treated with high-dose vitamin C infusion and was the first case to have early recovery from the disease at our institute. CASE REPORT A 74-year-old woman with no recent sick contacts or travel history presented with fever, cough, and shortness of breath. Her vital signs were normal except for oxygen saturation of 87% and bilateral rhonchi on lung auscultation. Chest radiography revealed air space opacity in the right upper lobe, suspicious for pneumonia. A nasopharyngeal swab for severe acute respiratory syndrome coronavirus-2 came back positive while the patient was in the airborne-isolation unit. Laboratory data showed lymphopenia and elevated lactate dehydrogenase, ferritin, and interleukin-6. The patient was initially started on oral hydroxychloroquine and azithromycin. On day 6, she developed ARDS and septic shock, for which mechanical ventilation and pressor support were started, along with infusion of high-dose intravenous vitamin C. The patient improved clinically and was able to be taken off mechanical ventilation within 5 days. CONCLUSIONS This report highlights the potential benefits of high-dose intravenous vitamin C in critically ill COVID-19 patients in terms of rapid recovery and shortened length of mechanical ventilation and ICU stay. Further studies will elaborate on the efficacy of intravenous vitamin C in critically ill COVID-19.
DOI: 10.12659/AJCR.925521
PubMed: 32709838
PubMed Central: PMC7405920
Links to Exploration step
pubmed:32709838Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Unusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C.</title><author><name sortKey="Waqas Khan, Hafiz Muhammad" sort="Waqas Khan, Hafiz Muhammad" uniqKey="Waqas Khan H" first="Hafiz Muhammad" last="Waqas Khan">Hafiz Muhammad Waqas Khan</name><affiliation><nlm:affiliation>Department of Cardiovascular Disease, McLaren-Flint/Michigan State University, Flint, MI, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Parikh, Niraj" sort="Parikh, Niraj" uniqKey="Parikh N" first="Niraj" last="Parikh">Niraj Parikh</name><affiliation><nlm:affiliation>Department of Pulmonary and Critical Care, McLaren-Flint/Michigan State University, Flint, MI, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Megala, Shady Maher" sort="Megala, Shady Maher" uniqKey="Megala S" first="Shady Maher" last="Megala">Shady Maher Megala</name><affiliation><nlm:affiliation>Department of Internal Medicine, McLaren-Flint/Michigan State University, Flint, MI, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Predeteanu, George Silviu" sort="Predeteanu, George Silviu" uniqKey="Predeteanu G" first="George Silviu" last="Predeteanu">George Silviu Predeteanu</name><affiliation><nlm:affiliation>Department of Cardiovascular Disease, McLaren-Flint/Michigan State University, Flint, MI, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32709838</idno><idno type="pmid">32709838</idno><idno type="doi">10.12659/AJCR.925521</idno><idno type="pmc">PMC7405920</idno><idno type="wicri:Area/Main/Corpus">001065</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001065</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Unusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C.</title><author><name sortKey="Waqas Khan, Hafiz Muhammad" sort="Waqas Khan, Hafiz Muhammad" uniqKey="Waqas Khan H" first="Hafiz Muhammad" last="Waqas Khan">Hafiz Muhammad Waqas Khan</name><affiliation><nlm:affiliation>Department of Cardiovascular Disease, McLaren-Flint/Michigan State University, Flint, MI, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Parikh, Niraj" sort="Parikh, Niraj" uniqKey="Parikh N" first="Niraj" last="Parikh">Niraj Parikh</name><affiliation><nlm:affiliation>Department of Pulmonary and Critical Care, McLaren-Flint/Michigan State University, Flint, MI, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Megala, Shady Maher" sort="Megala, Shady Maher" uniqKey="Megala S" first="Shady Maher" last="Megala">Shady Maher Megala</name><affiliation><nlm:affiliation>Department of Internal Medicine, McLaren-Flint/Michigan State University, Flint, MI, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Predeteanu, George Silviu" sort="Predeteanu, George Silviu" uniqKey="Predeteanu G" first="George Silviu" last="Predeteanu">George Silviu Predeteanu</name><affiliation><nlm:affiliation>Department of Cardiovascular Disease, McLaren-Flint/Michigan State University, Flint, MI, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">The American journal of case reports</title><idno type="eISSN">1941-5923</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Ascorbic Acid (administration & dosage)</term><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>Coronavirus Infections (therapy)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Infusions, Intravenous (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (therapy)</term><term>Recovery of Function (MeSH)</term><term>Respiration, Artificial (methods)</term><term>SARS-CoV-2 (MeSH)</term><term>Vitamins (administration & dosage)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Ascorbic Acid</term><term>Vitamins</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Respiration, Artificial</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Betacoronavirus</term><term>COVID-19</term><term>Female</term><term>Humans</term><term>Infusions, Intravenous</term><term>Pandemics</term><term>Recovery of Function</term><term>SARS-CoV-2</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">BACKGROUND Coronavirus disease 2019 (COVID-19) continues to spread, with confirmed cases now in more than 200 countries. Thus far there are no proven therapeutic options to treat COVID-19. We report a case of COVID-19 with acute respiratory distress syndrome who was treated with high-dose vitamin C infusion and was the first case to have early recovery from the disease at our institute. CASE REPORT A 74-year-old woman with no recent sick contacts or travel history presented with fever, cough, and shortness of breath. Her vital signs were normal except for oxygen saturation of 87% and bilateral rhonchi on lung auscultation. Chest radiography revealed air space opacity in the right upper lobe, suspicious for pneumonia. A nasopharyngeal swab for severe acute respiratory syndrome coronavirus-2 came back positive while the patient was in the airborne-isolation unit. Laboratory data showed lymphopenia and elevated lactate dehydrogenase, ferritin, and interleukin-6. The patient was initially started on oral hydroxychloroquine and azithromycin. On day 6, she developed ARDS and septic shock, for which mechanical ventilation and pressor support were started, along with infusion of high-dose intravenous vitamin C. The patient improved clinically and was able to be taken off mechanical ventilation within 5 days. CONCLUSIONS This report highlights the potential benefits of high-dose intravenous vitamin C in critically ill COVID-19 patients in terms of rapid recovery and shortened length of mechanical ventilation and ICU stay. Further studies will elaborate on the efficacy of intravenous vitamin C in critically ill COVID-19.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32709838</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1941-5923</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><PubDate><Year>2020</Year><Month>Jul</Month><Day>25</Day></PubDate></JournalIssue><Title>The American journal of case reports</Title><ISOAbbreviation>Am J Case Rep</ISOAbbreviation></Journal><ArticleTitle>Unusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C.</ArticleTitle><Pagination><MedlinePgn>e925521</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12659/AJCR.925521</ELocationID><Abstract><AbstractText>BACKGROUND Coronavirus disease 2019 (COVID-19) continues to spread, with confirmed cases now in more than 200 countries. Thus far there are no proven therapeutic options to treat COVID-19. We report a case of COVID-19 with acute respiratory distress syndrome who was treated with high-dose vitamin C infusion and was the first case to have early recovery from the disease at our institute. CASE REPORT A 74-year-old woman with no recent sick contacts or travel history presented with fever, cough, and shortness of breath. Her vital signs were normal except for oxygen saturation of 87% and bilateral rhonchi on lung auscultation. Chest radiography revealed air space opacity in the right upper lobe, suspicious for pneumonia. A nasopharyngeal swab for severe acute respiratory syndrome coronavirus-2 came back positive while the patient was in the airborne-isolation unit. Laboratory data showed lymphopenia and elevated lactate dehydrogenase, ferritin, and interleukin-6. The patient was initially started on oral hydroxychloroquine and azithromycin. On day 6, she developed ARDS and septic shock, for which mechanical ventilation and pressor support were started, along with infusion of high-dose intravenous vitamin C. The patient improved clinically and was able to be taken off mechanical ventilation within 5 days. CONCLUSIONS This report highlights the potential benefits of high-dose intravenous vitamin C in critically ill COVID-19 patients in terms of rapid recovery and shortened length of mechanical ventilation and ICU stay. Further studies will elaborate on the efficacy of intravenous vitamin C in critically ill COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Waqas Khan</LastName><ForeName>Hafiz Muhammad</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Disease, McLaren-Flint/Michigan State University, Flint, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parikh</LastName><ForeName>Niraj</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care, McLaren-Flint/Michigan State University, Flint, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Megala</LastName><ForeName>Shady Maher</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, McLaren-Flint/Michigan State University, Flint, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Predeteanu</LastName><ForeName>George Silviu</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Disease, McLaren-Flint/Michigan State University, Flint, MI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Case Rep</MedlineTA><NlmUniqueID>101489566</NlmUniqueID><ISSNLinking>1941-5923</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="Y">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32709838</ArticleId><ArticleId IdType="pii">925521</ArticleId><ArticleId IdType="doi">10.12659/AJCR.925521</ArticleId><ArticleId IdType="pmc">PMC7405920</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Br J Nutr. 2007 Oct;98 Suppl 1:S29-35</Citation><ArticleIdList><ArticleId IdType="pubmed">17922955</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrients. 2017 Mar 29;9(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">28353648</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2011 Jun;39(6):1454-60</Citation><ArticleIdList><ArticleId IdType="pubmed">21358394</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Feb 23;315(8):788-800</Citation><ArticleIdList><ArticleId IdType="pubmed">26903337</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrients. 2017 Nov 03;9(11):</Citation><ArticleIdList><ArticleId IdType="pubmed">29099763</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Feb 7;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrients. 2019 Mar 27;11(4):</Citation><ArticleIdList><ArticleId IdType="pubmed">30934660</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2019 Oct 1;322(13):1261-1270</Citation><ArticleIdList><ArticleId IdType="pubmed">31573637</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Mar 19;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32191259</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Signal. 2017 Mar 28;10(472):</Citation><ArticleIdList><ArticleId IdType="pubmed">28351945</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 May 21;382(21):2012-2022</Citation><ArticleIdList><ArticleId IdType="pubmed">32227758</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Immunol. 1999 May 25;194(1):1-5</Citation><ArticleIdList><ArticleId IdType="pubmed">10357874</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Mar 13;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32167538</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2020 May;8(5):475-481</Citation><ArticleIdList><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>J Transl Med. 2014 Jan 31;12:32</Citation><ArticleIdList><ArticleId IdType="pubmed">24484547</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001065 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001065 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32709838
|texte= Unusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32709838" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |